Home
Conditions
Leukemia, Plasma Cell

Clinical trial condition

Leukemia, Plasma Cell

Explore clinical trials studying Leukemia, Plasma Cell. Study availability and eligibility vary by location and protocol.

48 public trials 24 recruiting studies

Refine in advanced search Browse all conditions

Leukemia, Plasma Cell trial results

Recruiting

Testing an Experimental Approach to Treat Patients With Plasma Cell Leukemia, The QUANTUM Trial

NCT07605416

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Alliance for Clinical Trials in Oncology Chicago, Illinois, United States

View Trial Details

Recruiting

Phase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological Malignances

NCT05092451

Conditions: Acute Myeloid Leukemia (AML), B-cell Lymphoma, Blastic Transformation of Chronic Myeloid Leukemia, +39 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

The Norwegian Immunotherapy in Multiple Myeloma Study

NCT06855121

Conditions: AL Amyloidosis, Amyloidosis, Blood Protein Disorders, +23 more
Locations: Sørlandet Hospital - Arendal Arendal, Norway

Ålesund hospital, Department of hematology Ålesund, Norway

Haukeland University Hospital Bergen, Norway

Bodø Hospital Bodø, Norway

View all 23 locations

View Trial Details

Recruiting

Personalising Treatment for Myeloma Patients Based on Initial Response to NHS Treatment and Their Overall Fitness Level

NCT07649525

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Frailty, +19 more
Locations: Bristol Haematology and Oncology Centre Bristol, United Kingdom

Eastbourne District General Hospital Eastbourne, United Kingdom

St James University Hospital Leeds, United Kingdom

The Clatterbridge Cancer Centre - Liverpool Liverpool, United Kingdom

View Trial Details

Recruiting

Allo HSCT Using RIC and PTCy for Hematological Diseases

NCT05805605

Conditions: Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Biphenotypic Acute Leukemia, +54 more
Locations: Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States

View Trial Details

Recruiting

Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders

NCT03314974

Conditions: Acquired Bone Marrow Failure Syndromes, Acute Leukemia, Acute Lymphoblastic Leukemia, +74 more
Locations: Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States

View Trial Details

Recruiting

Impact of Budesonide on Incidence of ≥ Gr2 Diarrhea in Multiple Myeloma (MM) Patients Undergoing Autologous Stem Cell Transplant

NCT05405387

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
Locations: Huntsman Cancer Institute at the University of Utah Salt Lake City, Utah, United States

View Trial Details

Recruiting

Adaptive Dual-Target CAR-T Cells for Relapsed or Refractory Hematologic Malignancies

NCT07523555

Conditions: BPDCN; Relapsed/Refractory T-cell Acute Lymphoblastic Leukemia, Blastic Plasmacytoid Dendritic Cell Neoplasm, Blood Protein Disorders, +50 more
Locations: Peking University Shenzhen Hospital Shenzhen, Guangdong, China

View Trial Details

Recruiting

IL-15-Armored CAR-T Therapy in Relapsed or Refractory Multiple Myeloma and Plasma Cell Leukemia

NCT07509086

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +16 more
Locations: The First Hospital of Jilin University Changchun, Jilin, China

View Trial Details

Recruiting

Cancer and Aging Resilience Evaluation in Older Adults With Hematologic Malignancies: The CARE-Heme Registry

NCT05556928

Conditions: Amyloidosis, Blood Protein Disorders, Cardiovascular Diseases, +19 more
Locations: Kirklin Clinic of UAB Hospital Birmingham, Alabama, United States

View Trial Details

Leukemia, Plasma Cell

Leukemia, Plasma Cell trial results

Related conditions